Tempo reale stimato
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
15,54 USD | -0,10% | -0,26% | -21,78% |
Attività
Numero di dipendenti: 79
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Chief Executive Officer | 59 | 01/02/20 | |
Mark Hahn
DFI | Director of Finance/CFO | 61 | 01/03/20 |
Kavita Aggarwal
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/23 |
Tara Rheault
CTO | Chief Tech/Sci/R&D Officer | 49 | 01/01/19 |
Kathleen Rickard
CTO | Chief Tech/Sci/R&D Officer | 65 | 01/02/19 |
Victoria Stewart
IRC | Investor Relations Contact | - | 01/02/19 |
Corporate Officer/Principal | - | 01/06/20 | |
Ostra Jewell
HRO | Human Resources Officer | - | 01/09/22 |
Caroline Diaz
LAW | General Counsel | - | 01/10/21 |
Matthew Casbon
SAM | Sales & Marketing | - | 24/08/22 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Mahendra Shah
BRD | Director/Board Member | 79 | 17/06/16 |
Vikas Sinha
BRD | Director/Board Member | 60 | 12/09/16 |
David Ebsworth
CHM | Chairman | 69 | 01/12/14 |
Director/Board Member | 71 | 10/09/15 | |
Martin Edwards
BRD | Director/Board Member | 68 | 01/04/19 |
Sven Ullman
BRD | Director/Board Member | 68 | 10/09/15 |
Chief Executive Officer | 59 | 01/02/20 | |
Director/Board Member | 59 | 01/09/23 | |
Lisa Deschamps
BRD | Director/Board Member | 52 | 01/03/21 |
James Brady
BRD | Director/Board Member | 61 | 14/03/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 608 138 246 | 458 671 402 ( 75,42 %) | 0 | 75,42 % |
Coordinate società
Settore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-21,78% | 1,26 Mrd | |
-3,17% | 102 Mrd | |
+1,95% | 96,29 Mrd | |
+2,15% | 22,18 Mrd | |
-15,39% | 21,2 Mrd | |
-9,21% | 18,31 Mrd | |
-39,98% | 17,38 Mrd | |
-15,70% | 16,36 Mrd | |
+5,34% | 13,97 Mrd | |
+32,92% | 12,17 Mrd |
- Borsa valori
- Azioni
- Azione VRNA
- Società Verona Pharma plc